CytRx Corp.

CytRx Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.42
Market Cap
$12.36 M
Shares Outstanding
33.64 M
Public Float
30.78 M

Profile

Address
11726 San Vicente Boulevard
Los Angeles California 90049
United States
Employees -
Website http://www.cytrx.com
Updated 07/08/2019
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It focuses on discovering, developing, and commercializing new therapeutics to treat patients with cancer; including aldoxorubicin, a modified version of the widely-used chemotherapeutic agent, doxorubicin. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Financials

View All

Steven A. Kriegsman
Chairman & Chief Executive Officer
Joel Caldwell
Director